Plasma exchange for renal disease: Evidence and use 2011

Journal of Clinical Apheresis

Volumn 27, Issue 3, 2012, Pages 112-116

  Clark, W F ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

ANCA; myeloma; renal; therapeutic apheresis; therapeutic plasma exchange

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

CONFERENCE PAPER; CRYOGLOBULINEMIA; EVIDENCE BASED PRACTICE; GOODPASTURE SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT; MEDICAL SOCIETY; MYELOMA; PLASMAPHERESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; VASCULITIS;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CANADA; CRYOGLOBULINEMIA; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; PLASMA EXCHANGE; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 84861833839     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21221     Document Type: Conference Paper

References (28)

1. Lockwood CM, Boulton-Jones JM, Lowenthal RM, Simpson IJ, Peters DK,. Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis. Br Med J 1975; 2: 252-254.
2. Clark WF, Rock GA, Buskard N, Shumak KH, LeBlond P, Anderson D, Sutton DM,. Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Inter Med 1999; 131: 453-462.
3. Moschcowitz E,. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries. An undescribed disease. Arch Internal Med 1925; 36: 89-93.
4. Gasser C, Gauthier E, Steck A, et al. Hamolytisch-uramische syndromes bilaterale nierenrindennekrosen bei akuten erworbenchen hamolytischen anamien. Schweiz Med Wschr 1955; 85: 905-909.
5. Rubenstein MA, Kagan BM, MacGillviray MH, Merliss R, Sacks H,. Unusual remission in a case of thrombotic thrombocytopenia purpura syndrome following fresh blood exchange transfusions. Annals Internal Med 1959; 51: 1409-1419.
6. Bukowski RM, King JW, Hewlett JS,. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 1977; 50: 413-417.
7. Byrnes JJ, Khurana M,. Treatment of thrombotic thrombocytopenic purpura with plasma. NEJM 1977; 297: 1386-1389.
8. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA,; the Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenia purpura. NEJM 1991; 325: 393-397.
9. Tsai H-M, Lian E C-Y,. Antibodies to Von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. NEJM 1998; 339: 1585-1594.
10. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B,. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-1584.
11. Vesely SK, George JN, Lammle B, Studt J-D, Alberio L, El-Harake MA, Raskob GE,. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003; 102: 60-68.
12. Amorosi EL, Ultmann JE,. Thrombotic thrombocytopenic purpura: report of 16 cases and review of literature. Medicine (Baltimore) 1966; 45: 139-159.
13. Cohen JA, Brecher ME, Bandarenko N,. Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. J Clin Apher 1998; 13: 16-19.
14. Fujimara Y, Matsumoto M, Yagi H,. Thrombotic microangiopathy. In:, Tanaka K, Davie EW, editors. Recent Advances in Thrombosis and Hemostasis, 1st ed. Tokyo, Japan: Springer 2008. p XXI, pp. 625- 639.
15. Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, Mirapeix E, Savage CO, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, deLind van Wijngaarden RA, Pusey CD,; European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007; 18: 2180-2188.
16. Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL,. Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 2011; 365: 318-326.
17. Tobian AA, Shirey RS, Montgomery RA, Ness PM, King KE,. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion 2008; 48: 2453-2460; Review.
18. Karthikeyan V, Parasuraman R, Shah V, Vera E, Venkat KK,. Outcome of Plasma exchange therapy in thrombotic microangiopathy after renal transplantation. Am J Transplant 2003; 3: 1289-1294.
19. Swainson CP, Robson JS, Urbaniak SJ, Keller AJ, Kay AB,. Treatment of Goodpasture's disease by plasma exchange and immunosuppression. Clin Exp Immunol 1978; 32: 233-242.
20. Johnson JP, Moore J Jr., Austin HA III, Balow JE, Antonovych TT, Wilson CB,. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 1985; 64: 219-227.
21. Levy JB, Turner AN, Rees AJ, Pusey CD,. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001; 134: 1033-1042.
22. Andresdottir MB, Ajubi N, Croockewit S, Assmann KJ, Hibrands LB, Wetzels JF,. Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999; 14: 2650-2656.
23. Rockx MA, Clark WF,. Plasma exchange for treating cryoglobulinemia: a descriptive analysis. Transfus Apher Sci 2010; 42: 247-251.
24. Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, Heidenheim AP, Garg AX, Churchill DN,; Canadian Apheresis Group. Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 2005; 143: 777-784. Erratum in: Ann Intern Med 2007; 146: 471.
25. Pillon L, Sweeting RS, Arora A, Notkin A, Ballard HS, Wieczorek RL, Leung N,. Approach to acute renal failure in biopsy proven myeloma cast nephropathy: is there still a role for plasmapheresis? Kidney Int 2008; 74: 956-961.
26. Kastritis E, Anagnostopoulos A, Roussou M, Gika D, Matsouka C, Barmparousi D, Grapsa I, Psimenou E, Bamias A, Dimopoulos MA,. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents. Haematologica 2007; 92: 546-549.
27. Clark WF, Garg AX,. Plasma exchange for myeloma kidney: cast(s) away? Kidney Int 2008; 73: 1211-1213.
28. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM,. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med 1992; 326: 1373-1379.